Authors


Timothy P. Hofer, MD, MSc

Latest:

Evaluating Alternative Methods of Comparing Antihypertensive Treatment Intensity

Medication dose captures modification of hypertension treatment intensity more precisely than medication count, and this measure should be preferred in studies that aim to improve hypertension management.


Robert “Bo” Gamble

Latest:

Cancer Care Value-Learning From Others

Getting Smarter in How We Score and Promote Value


Mei-Shu Lai, MD, PhD

Latest:

Effect of the Pay-for-Performance Program for Breast Cancer Care in Taiwan

The pay-for-performance program for breast cancer care had a positive impact on breast cancer outcome in Taiwan. Enrollees received better quality care and had better outcome.


Constantine A. Mantz, MD

Latest:

Extending Cancer Care Past Remission: The Importance of Cardiac Toxicity Monitoring and Awareness

Medical monitoring and counseling can help us track and contain many harmful effects of cancer drug-induced cardiotoxicity. Patient engagement from the very beginning, along with medically advanced testing methods, can help us surmount cardiotoxicity and better ensure that patients receive only the benefits of essential cancer treatment.


Karen Tu, MD, MSc

Latest:

Evaluation of Electronic Medical Record Administrative Data Linked Database (EMRALD)

The combination of electronic medical record data and administrative data provides the fullest picture of patient health histories.



Geoff Joyce, PhD

Latest:

Medicaid Prior Authorization Policies and Imprisonment Among Patients With Schizophrenia

This study examined the impact of prior authorization formularies on the likelihood that patients with schizophrenia will be arrested and incarcerated.



Sarah J. Nigro, PharmD

Latest:

Evaluation of Collaborative Therapy Review to Improve Care of Heart Failure Patients

We implemented and evaluated a collaborative therapy review process aimed at optimizing heart failure therapy among patients managed by their primary care providers.


Seth P. McCullock, MA

Latest:

Preventive/Office Visit Patient Knowledge and Their Insurance Information Gathering Perceptions

Patients have an incomplete understanding of what constitutes no-cost preventive care services. Ease of obtaining information from insurance companies can significantly affect whether patients are charged correctly.


Thomas Shaffer, MHS

Latest:

Medication Adherence and Medicare Expenditure Among Beneficiaries With Heart Failure

Modest increases in adherence to medication regimens among Medicare patients with heart failure were associated with lower Medicare spending in 3 major drug classes.


Seth A. Seabury, PhD

Latest:

Medication Adherence as a Measure of the Quality of Care Provided by Physicians

Physician-level medication adherence is a strong predictor of patient health and should be considered as a measure of physician quality.


Ashar Ata, MBBS, MPH, PhD

Latest:

A Novel Nursing-Driven Standardized Diabetes Education Process in Primary Care

A new nursing-driven diabetes education process established within a patient-centered primary care model significantly improved diabetes control for veterans at the Albany Stratton VA Medical Center.


Joanna Campbell, PhD

Latest:

Cost-Effectiveness of Laparoscopic Gastric Banding and Bypass for Morbid Obesity

Laparoscopic adjustable gastric banding and gastric bypass are cost-effective treatments for morbid obesity compared with no treatment.




Jeno P. Marton, MD

Latest:

Can Outpatient Pharmacy Data Identify Persons With Undiagnosed COPD?

Algorithms based on managed care pharmacy data can efficiently identify persons at risk for undiagnosed chronic obstructive pulmonary disease.


Linda F. McCaig, MPH

Latest:

Ambulatory Care Visits for Pap Tests, Abnormal Pap Test Results, and Cervical Cancer Procedures in the United States

The pre-HPV vaccination burden of ambulatory care visits and procedures related to cervical cancer screening is assessed, with projected effects of HPV vaccination and testing.


Susan L. Mitchell, MD, MPH

Latest:

Medicare Part D Claims Rejections for Nursing Home Residents, 2006 to 2010

This study presents data on paid and rejected claims submitted by 1 large long-term care pharmacy over the initial 5 years of Medicare Part D.



James J. Hill III, MD, MPH

Latest:

Drug Adherence After Price Changes in a Previously Compliant Population

The impact of price changes in drugs, at least among previously adherent patients, was modest in size except for drugs with large price changes.



Sally C. Stearns, PhD

Latest:

Short-Term Costs Associated With Primary Prophylactic G-CSF Use During Chemotherapy

Granulocyte colony-stimulating factor therapy reduces hospitalizations and improves chemotherapy administration in elderly breast cancer patients, but increases overall Medicare costs during first year of therapy.


Claude R. Maechling, PhD

Latest:

Employer-Led Efforts to Improve the Value of Health Spending

Findings from a systematic review show that employer-led efforts to date have produced few promising strategies for improving the value of health spending.


Deena Mary Atieh Graham, MD

Latest:

Real-World Economic Value of a 21-Gene Assay in Early-Stage Breast Cancer

Universal gene expression profiling of patients with stage II breast cancer resulted in outpatient savings of $11,000 (inclusive of testing costs) within 6 months of initiation of medical therapy.






AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo